Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination.
J Infect Dis
; 219(1): 41-49, 2019 01 01.
Article
in En
| MEDLINE
| ID: mdl-30085139
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunization, Secondary
/
Vaccination
/
Papillomavirus Infections
/
Papillomavirus Vaccines
/
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
Language:
En
Journal:
J Infect Dis
Year:
2019
Type:
Article
Affiliation country:
Mexico